Email Alert | RSS

Journal of Peking University (Health Sciences) ›› 2021, Vol. 53 ›› Issue (2): 348-354. doi: 10.19723/j.issn.1671-167X.2021.02.020

Previous Articles     Next Articles

Preparation and in vitro evaluation of fused deposition modeling 3D printed verapa-mil hydrochloride gastric floating formulations

CHEN Di1,XU Xiang-yu2,WANG Ming-rui1,LI Rui1,ZANG Gen-ao2,ZHANG Yue1,QIAN Hao-nan1,YAN Guang-rong2,Δ(),FAN Tian-yuan1,Δ()   

  1. 1. Department of Pharmaceutics, Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, Peking University School of Pharmaceutical Sciences, Beijing 100191, China
    2. School of Mechanical Engineering and Automation, Beihang University, Beijing 100191, China
  • Received:2019-05-05 Online:2021-04-18 Published:2021-04-21
  • Contact: Guang-rong YAN,Tian-yuan FAN E-mail:yangr@buaa.edu.cn;tianyuan_fan@bjmu.edu.cn

RICH HTML

   

PDF (PC)

Abstract:

Objective: To explore the feasibility of preparing gastric floating formulations by fused de-position modeling (FDM) 3D printing technology, to evaluate the in vitro properties of the prepared FDM 3D printed gastric floating formulations, and to compare the influence of different external shapes of the formulation with their in vitro properties. Methods: Verapamil hydrochloride and polyvinyl alcohol (PVA) were used as the model drug and the excipient, respectively. The capsule-shaped and hemisphere-shaped gastric floating formulations were then prepared by FDM 3D printing. The infill percentages were 15%, the layer heights were 0.2 mm, and the roof or floor thicknesses were 0.8 mm for both the 3D printed formulations, while the number of shells was 3 and 4 for capsule-shaped and hemisphere-shaped formulation, respectively. Scanning electron microscopy (SEM) was used to observe the morpho-logy of the surface and cross section of the formulations. Gravimetric method was adopted to measure the weights of the formulations. Texture analyzer was employed to evaluate the hardness of the formulations. High performance liquid chromatography method was used to determine the drug contents of the formulations. The in vitro floating and drug release behavior of the formulations were also characterized. Results: SEM showed that the appearance of the FDM 3D printed gastric floating formulations were both intact and free from defects with the filling structure which was consistent with the design. The weight variations of the two formulations were relatively low, indicating a high reproducibility of the 3D printing fabrication. Above 800.0 N of hardness was obtained in two mutually perpendicular directions for the two formulations. The drug contents of the two formulations approached to 100%, showing no drug loss during the 3D printing process. The two formulations floated in vitro without any lag time, and the in vitro floating time of the capsule-shaped and hemisphere-shaped formulation were (3.97±0.41) h and (4.48±0.21) h, respectively. The in vitro release of the two formulations was significantly slower than that of the commercially available immediate-release tablets. Conclusion: The capsule-shaped and hemisphere-shaped verapamil hydrochloride gastric floating formulations were prepared by FDM 3D printing technology successfully. Only the floating time was found to be influenced by the external shape of the 3D printed formulations in this study.

Key words: Fused deposition modeling, Printing, three-dimensional, Verapamil, Gastric floating formulation

CLC Number: 

  • R944.9

Figure 1

Schematic diagram of FDM 3D printed gastric floating formulations A, C, capsule; B, D, hemisphere. a and b represent the length and height of the formulations, respectively."

Figure 2

Illustration of the infill structure of the FDM 3D printed gastric floating formulations A, capsule; B, hemisphere."

Table 1

Parameters of the FDM 3D printed gastric floating formulations"

Formulations Size/mm Layer height/mm Floor or roof thickness/mm Number of shells Infill percentage/%
a b
Capsule 17.7 6.8 0.2 0.8 3 15
Hemisphere 11.4 7.8 0.2 0.8 4 15

Figure 3

Illustration of the applied force in two perpendicular directions (direction Ⅰ and direction Ⅱ) measuring the hardness of the formulations"

Figure 4

Photos of the FDM 3D printed gastric floating formulations A, appearance of capsule; B, section of capsule; C, appearance of he-misphere; D, section of hemisphere."

Figure 5

SEM images of the FDM 3D printed gastric floating formulations A, surface of capsule; B, section of capsule; C, surface of hemisphere; D, section of hemisphere."

Table 2

Characterization results of the FDM 3D printed gastric floating formulations"

Formulations Weight/mg Hardness/N Lag time/s Floating time/h
Direction Ⅰ Direction Ⅱ
Capsule 584±13 >800.0 >800.0 0 3.97±0.41
Hemisphere 550±12 >800.0 >800.0 0 4.48±0.21

Figure 6

In vitro drug release curves of conventional tablet, capsule and hemisphere FDM 3D printed gastric floating formulations"

[1] Kaushik AY, Tiwari AK, Gaur A. Role of excipients and polyme-ric advancements in preparation of floating drug delivery systems[J]. Int J Pharm Investig, 2015,5(1):1-12.
[2] Pawar VK, Kansal S, Garg G, et al. Gastroretentive dosage forms: A review with special emphasis on floating drug delivery systems[J]. Drug Deliv, 2011,18(2):97-110.
pmid: 20958237
[3] Kotreka UK, Adeyeye MC. Gastroretentive floating drug-delivery systems: A critical review[J]. Crit Rev Ther Drug Carrier Syst, 2011,28(1):47-99.
[4] Sauzet C, Claeys-Bruno M, Nicolas M, et al. An innovative floating gastro retentive dosage system: formulation and in vitro evaluation[J]. Int J Pharm, 2009,378(1/2):23-29.
[5] Sungthongjeen S, Paeratakul O, Limmatvapirat S, et al. Preparation and in vitro evaluation of a multiple-unit floating drug delivery system based on gas formation technique[J]. Int J Pharm, 2006,324(2):136-143.
[6] Alexander S, Juergen S, Roland B. Gastroretentive drug delivery systems[J]. Expert Opinion on Drug Delivery, 2006,3(2):217-233.
pmid: 16506949
[7] Konta AA, Garcia-Pina M, Serrano DR. Personalised 3D printed medicines: Which techniques and polymers are more successful?[J]. Bioengineering (Basel), 2017,4(4):79-96.
[8] Long J, Gholizadeh H, Lu J, et al. Application of fused deposition modelling (FDM) method of 3D printing in drug delivery[J]. Curr Pharm Des, 2017,23(3):433-439.
[9] Palo M, Hollander J, Suominen J, et al. 3D printed drug delivery devices: Perspectives and technical challenges[J]. Expert Rev Med Devices, 2017,14(9):685-696.
[10] Alhnan MA, Okwuosa TC, Sadia M, et al. Emergence of 3D printed dosage forms: Opportunities and challenges[J]. Pharm Res, 2016,33(8):1817-1832.
pmid: 27194002
[11] Sawicki W, Glod J. Preparation of floating pellets with verapamil hydrochloride[J]. Acta Pol Pharm, 2004,61(3):185-190.
[12] Patel A, Modasiya M, Shah D, et al. Development and in vivo floating behavior of verapamil HCl intragastric floating tablets[J]. AAPS PharmSciTech, 2009,10(1):310-315.
[13] 范田园, 张悦. 一种3D打印胃漂浮制剂及其制备方法: 中国,CN106692091A[P]. 2017-05-24.
[14] Srikanth MV, Rao NS, Sunil SA, et al. Statistical design and evaluation of a propranolol HCl gastric floating tablet[J]. Acta Pharmaceutica Sinica B, 2012,2(1):60-69.
[15] Fu J, Yin H, Yu X, et al. Combination of 3D printing technologies and compressed tablets for preparation of riboflavin floating tablet-in-device (TiD) systems[J]. Int J Pharm, 2018,549(1/2):370-379.
[16] Goyanes A, Buanz AB, Hatton GB, et al. 3D printing of modified-release aminosalicylate (4-ASA and 5-ASA) tablets[J]. Eur J Pharm Biopharm, 2015,89:157-162.
pmid: 25497178
[17] Fuenmayor E, Forde M, Healy AV, et al. Comparison of fused-filament fabrication to direct compression and injection molding in the manufacture of oral tablets[J]. Int J Pharm, 2019,558:328-340.
pmid: 30659922
[18] Yang Y, Wang H, Li H, et al. 3D printed tablets with internal scaffold structure using ethyl cellulose to achieve sustained ibuprofen release[J]. Eur J Pharm Sci, 2018,115:11-18.
[19] Tagami T, Nagata N, Hayashi N, et al. Defined drug release from 3D-printed composite tablets consisting of drug-loaded polyvinylalcohol and a water-soluble or water-insoluble polymer filler[J]. Int J Pharm, 2018,543(1/2):361-367.
[20] Solanki NG, Tahsin M, Shah AV, et al. Formulation of 3D printed tablet for rapid drug release by fused deposition modeling: Screening polymers for drug release, drug-polymer miscibility and printability[J]. J Pharm Sci, 2018,107(1):390-401.
[21] Arafat B, Wojsz M, Isreb A, et al. Tablet fragmentation without a disintegrant: A novel design approach for accelerating disintegration and drug release from 3D printed cellulosic tablets[J]. Eur J Pharm Sci, 2018,118:191-199.
pmid: 29559404
[22] Kadry H, Al-Hilal TA, Keshavarz A, et al. Multi-purposable filaments of HPMC for 3D printing of medications with tailored drug release and timed-absorption[J]. Int J Pharm, 2018,544(1):285-296.
doi: 10.1016/j.ijpharm.2018.04.010 pmid: 29680281
[23] Sadia M, Arafat B, Ahmed W, et al. Channelled tablets: An innovative approach to accelerating drug release from 3D printed tablets[J]. J Control Release, 2018,269:355-363.
pmid: 29146240
[24] Tagami T, Fukushige K, Ogawa E, et al. 3D Printing factors important for the fabrication of polyvinylalcohol filament-based tablets[J]. Biol Pharm Bull, 2017,40(3):357-364.
[25] Goyanes A, Robles Martinez P, Buanz A, et al. Effect of geometry on drug release from 3D printed tablets[J]. Int J Pharm, 2015,494(2):657-663.
pmid: 25934428
[26] Zhang J, Yang W, Vo AQ, et al. Hydroxypropyl methylcellulose-based controlled release dosage by melt extrusion and 3D printing: Structure and drug release correlation[J]. Carbohydr Polym, 2017,177:49-57.
pmid: 28962795
[27] Goyanes A, Wang J, Buanz A, et al. 3D printing of medicines: Engineering novel oral devices with unique design and drug delease characteristics[J]. Mol Pharm, 2015,12(11):4077-4084.
pmid: 26473653
[28] Lunio R, Sawicki W. Influence of the components of Kollicoat SR film on mechanical properties of floating pellets from the point of view of tableting[J]. Pharmazie, 2008,63(10):731-735.
pmid: 18972835
[29] Yoshida MI, Gomes EC, Soares CD, et al. Thermal analysis applied to verapamil hydrochloride characterization in pharmaceutical formulations[J]. Molecules, 2010,15(4):2439-2452.
pmid: 20428054
[30] Soppimath KS, Kulkarni AR, Aminabhavi TM. Development of hollow microspheres as floating controlled-release systems for car-diovascular drugs: Preparation and release characteristics[J]. Drug Dev Ind Pharm, 2001,27(6):507-515.
pmid: 11548857
[31] Durig T, Fassihi R. Evaluation of floating and sticking extended release delivery systems: An unconventional dissolution test[J]. J Control Release, 2000,67(1):37-44.
pmid: 10773327
[32] Sawicki W, Lunio R, Walentynowicz O, et al. Influence of the type of cellulose on properties of multi-unit target releasing in sto-mach dosage form with verapamil hydrochloride[J]. Acta Pol Pharm, 2007,64(1):81-88.
pmid: 17665855
[1] Aonan WEN, Xiaohui ZHANG, Yongtao YANG, Zixiang GAO, Wenbo LI, Shenyao SHAN, Xiangyi SHANG, Yuwen TIAN, Shuwei GUO, Yizhen WANG, Yong WANG, Yijiao ZHAO. Method of constructing 3D facial smile simulation sequence data based on non-rigid registration [J]. Journal of Peking University (Health Sciences), 2026, 58(1): 139-144.
[2] Liang SHAO, Wenjie MA, Ying CHEN, Qian DING, Lei ZHANG. Digital measurement and analysis of anatomical characteristics of protrusive and intercuspal position occlusal contacts in maxillary incisors [J]. Journal of Peking University (Health Sciences), 2026, 58(1): 99-106.
[3] Jianxiao ZHAO, Qian DING, Wenjin LI, Quanquan MA, Yixiao LAN, Lei ZHANG, Jianmin HAN. Effect of porous surface structure on fatigue strength of 3D printed zirconia [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1165-1173.
[4] Yujia XIAO, Bochun MAO, Yanheng ZHOU. Three-dimensional morphological analysis of posed smile [J]. Journal of Peking University (Health Sciences), 2025, 57(5): 989-995.
[5] Shuyuan MIN, Yun TIAN. Biocompatibility of 3D printed biodegradable WE43 magnesium alloy scaffolds and treatment of bone defects [J]. Journal of Peking University (Health Sciences), 2025, 57(2): 309-316.
[6] Shiyu QIU, Yang LIAN, Yifan KANG, Lei ZHANG, Yiwang CAI, Xiaofeng SHAN, Zhigang CAI. Personalized mandibular reconstruction assisted by three-dimensional retrieval model based on fully connected neural network and a database of mandibles [J]. Journal of Peking University (Health Sciences), 2025, 57(2): 360-368.
[7] Lijuan MA, Yonghui TENG, Yong WANG, Yijiao ZHAO, Xinyue ZHANG, Qingzhao QIN, Dong YIN. Three-dimensional finite element analysis of digital wire loop space maintainers for missing deciduous teeth [J]. Journal of Peking University (Health Sciences), 2025, 57(2): 376-383.
[8] Yujia ZHU, Hua SHEN, Aonan WEN, Zixiang GAO, Qingzhao QIN, Shenyao SHAN, Wenbo LI, Xiangling FU, Yijiao ZHAO, Yong WANG. Deep learning algorithms for intelligent construction of a three-dimensional maxillofacial symmetry reference plane [J]. Journal of Peking University (Health Sciences), 2025, 57(1): 113-120.
[9] Xinxin ZHAN,Lulu CAO,Dong XIANG,Hao TANG,Dandan XIA,Hong LIN. Effect of printing orientation on physical and mechanical properties of 3D printing prosthodontic base resin materials [J]. Journal of Peking University (Health Sciences), 2024, 56(2): 345-351.
[10] Liang LYU,Mingjin ZHANG,Aonan WEN,Yijiao ZHAO,Yong WANG,Jing LI,Gengchen YANG,Dawei LIU. Preliminary evaluation of chin symmetry with three dimentional soft tissue spatial angle wireframe template [J]. Journal of Peking University (Health Sciences), 2024, 56(1): 106-110.
[11] Bochun MAO,Yajing TIAN,Xuedong WANG,Jing LI,Yanheng ZHOU. Soft and hard tissue changes of hyperdivergent class Ⅱ patients before and after orthodontic extraction treatment [J]. Journal of Peking University (Health Sciences), 2024, 56(1): 111-119.
[12] Xiaotong LING,Liuyang QU,Danni ZHENG,Jing YANG,Xuebing YAN,Denggao LIU,Yan GAO. Three-dimensional radiographic features of calcifying odontogenic cyst and calcifying epithelial odontogenic tumor [J]. Journal of Peking University (Health Sciences), 2024, 56(1): 131-137.
[13] Panpan HU,Yan LI,Xiao LIU,Yanchao TANG,Zihe LI,Zhongjun LIU. Clinical outcomes of 3D-printing stand-alone artificial vertebral body in anterior cervical surgeries [J]. Journal of Peking University (Health Sciences), 2024, 56(1): 161-166.
[14] Wen ZHANG,Xiao-jing LIU,Zi-li LI,Yi ZHANG. Effect of alar base cinch suture based on anatomic landmarks on the morphology of nasolabial region in patients after orthognathic surgery [J]. Journal of Peking University (Health Sciences), 2023, 55(4): 736-742.
[15] Meng-en OU,Yun DING,Wei-feng TANG,Yong-sheng ZHOU. Three-dimensional finite element analysis of cement flow in abutment margin-crown platform switching [J]. Journal of Peking University (Health Sciences), 2023, 55(3): 548-552.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright © Journal of Peking University (Health Sciences), All Rights Reserved.
Powered by Beijing Magtech Co. Ltd